Country Garden Venture Capital, New World Group and Ping An co-led a round for the computing system developer likely sized around the $425m mark.

Pfizer Ventures joined existing investors Ipsen and Leaps by Bayer and Pfizer Ventures in a round taking the oncology drug developer's overall funding to $174m.

The cancer treatment developer, co-founded by researchers from University of Chicago, has secured funding in a round co-led by Arix Bioscience and RTW Investments.

The cancer therapy developer, which is commercialising research from University of Texas, has raised series B1 and B2 financing.

The digital wallet developer has closed a series B round led by Qiming Venture Partners and backed by Wanxiang affiliate HashKey.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.

The truck management platform developer increased its overall funding to $31m in a series B round featuring Axa Venture Partners.

The Lockheed Martin-backed satellite launch system developer has now raised at least $219m of funding ahead of its first official launch.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.